- 関
- hematologic malignancy、hematologic neoplasm、hematological malignancy、hematopoietic malignancy、hematopoietic neoplasm
WordNet
- of or relating to or involved in hematology (同)haematological, hematological
PrepTutorEJDIC
- (体内にできる)新生物;腫瘍(しゅよう)
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 造血腫瘍の分類 classification of the hematopoietic neoplasms
- 2. 芽球性形質細胞様樹状細胞腫瘍 blastic plasmacytoid dendritic cell neoplasm
- 3. 硬化性粘液水腫 scleromyxedema
- 4. 腫瘍随伴性天疱瘡 paraneoplastic pemphigus
- 5. 銅欠乏性脊髄神経障害 copper deficiency myeloneuropathy
English Journal
- Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations.
- Verger E1, Cassinat B1, Chauveau A2, Dosquet C1, Giraudier S3, Schlageter MH1, Ianotto JC4, Yassin MA5, Al-Dewik N6, Carillo S7, Legouffe E8, Ugo V9, Chomienne C10, Kiladjian JJ11.
- Blood.Blood.2015 Dec 10;126(24):2585-91. doi: 10.1182/blood-2015-07-659060. Epub 2015 Oct 20.
- Myeloproliferative neoplasms are clonal disorders characterized by the presence of several gene mutations associated with particular hematologic parameters, clinical evolution, and prognosis. Few therapeutic options are available, among which interferon α (IFNα) presents interesting properties lik
- PMID 26486786
- Nine years without a new FDA-approved therapy for MDS: how can we break through the impasse?
- DeZern AE1.
- Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program.Hematology Am Soc Hematol Educ Program.2015 Dec 5;2015(1):308-16. doi: 10.1182/asheducation-2015.1.308.
- The myelodysplastic syndromes (MDSs) are a heterogeneous collection of clonal hematopoietic malignancies that compromise a large subgroup of the myeloid neoplasms and collectively are the most common acquired adult bone marrow failure syndromes. Currently, only 3 agents are approved for the treatmen
- PMID 26637738
- The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP).
- Malcovati L1, Cazzola M1.
- Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program.Hematology Am Soc Hematol Educ Program.2015 Dec 5;2015(1):299-307. doi: 10.1182/asheducation-2015.1.299.
- The WHO classification provides the best diagnostic approach to myelodysplastic syndromes (MDS). However, biologic and analytic limitations have emerged in the criteria currently adopted to establish the diagnosis and to classify MDS. The provisional category of idiopathic cytopenia of undetermined
- PMID 26637737
Japanese Journal
- Aberrant overexpression of membrane-associated mucin contributes to tumor progression in adult T-cell leukemia/lymphoma cells.
- Hasegawa Hiroo,Komoda Minori,Yamada Yasuaki,Yonezawa Suguru,Tsutsumida Hideaki,Nagai Kazuhiro,Atogami Sunao,Tsuruda Kazuto,Osaka Akemi,Sasaki Daisuke,Yanagihara Katsunori,Imaizumi Yoshitaka,Tsukasaki Kunihiro,Miyazaki Yasushi,Kamihira Shimeru
- Leukemia & Lymphoma 52(6), 1108-1117, 2011-06
- … Adult T-cell leukemia/lymphoma (ATL), an aggressive neoplasm etiologically associated with human T-lymphotropic virus type-1 (HTLV-1), exhibits invasive tropism into various organs, resulting in disease progression and resistance to treatment. … In the present study, we showed that MUC1 is overexpressed exclusively in cells of ATL among hematological malignancies. …
- NAID 120003751843
- New Strategy of Adult T-cell Leukemia Treatment Targeted for Anti-tumor Immunity and a Longevity Gene-encoded Protein
- 小迫 知弘
- YAKUGAKU ZASSHI 131(7), 1061-1072, 2011
- … Adult T-cell leukemia-lymphoma (ATL) is an aggressive peripheral T-cell neoplasm with a poor prognosis, developing after long-term infection with human T-cell leukemia virus-1 (HTLV-1). … Despite recent progress in both chemotherapy and supportive care for hematological malignancies, the prognosis of ATL is still poor; …
- NAID 130000926995
- 造血器腫瘍患者におけるClostridium difficile関連下痢症についての検討-千葉県がんセンタ一の5間の臨床学的検討-
- 酒井 力,熊谷 匡也,高木 敏之
- 日本化学療法学会雜誌 = Japanese journal of chemotherapy 47(1), 43-47, 1999-01-25
- NAID 10005864942
Related Links
- Hematological malignancies (British spelling "Haematological" malignancies) are the types of cancer that affect blood, bone marrow, and lymph nodes. As the three are intimately connected through the immune system, a disease affecting one ...
- 1: Hematologic Neoplasms Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life- threatening ...
Related Pictures
★リンクテーブル★
| リンク元 | 「hematologic malignancy」「hematological malignancy」「hematopoietic malignancy」「hematopoietic neoplasm」「hematologic neoplasm」 |
| 関連記事 | 「hematological」「neoplasm」「hematologic」 |
「hematologic malignancy」
- 関
- haematopoietic neoplasm、hematologic neoplasm、hematological malignancy、hematological neoplasm、hematopoietic malignancy、hematopoietic neoplasm
「hematological malignancy」
- 関
- haematopoietic neoplasm、hematologic malignancy、hematologic neoplasm、hematological neoplasm、hematopoietic malignancy、hematopoietic neoplasm
「hematopoietic malignancy」
- 関
- haematopoietic neoplasm、hematologic malignancy、hematologic neoplasm、hematological malignancy、hematological neoplasm、hematopoietic neoplasm
「hematopoietic neoplasm」
- 関
- haematopoietic neoplasm、hematologic malignancy、hematologic neoplasm、hematological malignancy、hematological neoplasm、hematopoietic malignancy
「hematologic neoplasm」
- 関
- hematologic malignancy、hematological malignancy、hematological neoplasm、hematopoietic malignancy、hematopoietic neoplasm
「hematological」
- 血液学的な、血液学の
- 関
- haematologic、haematological、haematologically、haematology、hematol、hematologic、hematologically、hematology
「neoplasm」
- n.
「hematologic」
- 血液学的な